← Eichor
Condition: Psilocybin Synced from ClinicalTrials.gov · July 30, 2026

Recruiting studies: Psilocybin

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD
Phase 2 · 1 location(s) · Sunstone Medical · NCT06902974Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought
Phase 1/Phase 2 · 1 location(s) · Johns Hopkins University · NCT05301608Psilocybin on Brain Mechanisms of Motivation in OUD
Phase 2 · 1 location(s) · University of Pennsylvania · NCT06810310A Randomized Neuroimaging Trial of Psilocybin in Depression
Phase 2 · 1 location(s) · Sunnybrook Health Sciences Centre · NCT06072898Psilocybin in the Treatment of Cannabis Use Disorder: A-Proof-of-Concept Study
Phase 2 · 1 location(s) · McMaster University · NCT06225232Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
Phase 2 · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06706232Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer
Phase 2 · 1 location(s) · Alan Davis · NCT07216404The Impact of Psilocybin on Pain in Fibromyalgia Patients
NA · 2 location(s) · Maastricht University · NCT06368492A Study of Psychedelics in Healthy Older Adults With Low Well-being
Phase 1 · 1 location(s) · Jennifer Mitchell · NCT07386730Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis
EARLY_Phase 1 · 1 location(s) · Johns Hopkins University · NCT06656702Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
Phase 2 · 1 location(s) · Johns Hopkins University · NCT06067737Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06200155Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers
Phase 2 · 1 location(s) · Robin Carhart-Harris, PhD, MA · NCT06626139Psilocybin for Methamphetamine Addiction
EARLY_Phase 1 · 1 location(s) · Kevin Murnane · NCT06899594Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder
Phase 2 · 1 location(s) · Queen's University · NCT06969170TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06801041PsiloIMAGINE: A Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm
EARLY_Phase 1 · 1 location(s) · Imperial College London · NCT06798636Mindfulness-assisted Psychedelic Therapy
Phase 2 · 1 location(s) · University of Southern California · NCT06233344Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young
Phase 2 · 1 location(s) · Region Skane · NCT07169747Wellcome Leap Psilocybin for OUD
Phase 2 · 1 location(s) · Anna Rose Childress, Ph.D. · NCT06786325Psilocybin Microdose for Psychological and Existential Distress in Palliative Care (PSYCHED-PAL-RCT)
Phase 3 · 7 location(s) · Bruyère Health Research Institute. · NCT07063862Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN
Phase 2 · 2 location(s) · Unity Health Toronto · NCT06731335Investigating the Persisting Effects of a Single Dose of Psilocybin on Structural Plasticity in Healthy Older Adults
Phase 1 · 1 location(s) · University of California, Berkeley · NCT06367738"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
Phase 3 · 47 location(s) · Cybin IRL Limited · NCT06564818Psilocybin for Opioid Use Disorder (OUD)
Phase 2 · 5 location(s) · NYU Langone Health · NCT06796062Psilocybin Therapy in Advanced Cancer
Phase 2/Phase 3 · 2 location(s) · NYU Langone Health · NCT05398484Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
Phase 1 · 2 location(s) · University of Colorado, Denver · NCT06430541Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs
Phase 1 · 1 location(s) · University College, London · NCT06815653Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms
Phase 3 · 8 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT07638553Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
Phase 1 · 6 location(s) · University of Colorado, Denver · NCT07516405
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.